1. In isolated pancreatic islets, pyruvate causes a shift to the left of the sigmoidal curve relating the rate of insulin release to the ambient glucose concentration. The magnitude of this effect is related to the concentration of pyruvate (5-90mM) and, at a 30mM concentration, is equivalent to that evoked by 2mM-glucose. Pyruvate between the concentration of reduced nicotinamide nucleotides and the net uptake of 45Ca. Menadione inhibits the effect of pyruvate on insulin release, without altering its rate of oxidation. 9. Pyruvate, like glucose, modestly stimulates lipogenesis. 10. Pyruvate, in contrast with glucose, markedly inhibits the oxidation of endogenous nutrients. The latter effect accounts for the apparent discrepancy between the rate of pyruvate oxidation and the magnitude of its insulinotropic action. 11. Dichloroacetate fails to affect glucose oxidation and glucose-stimulated insulin release. 12. It is concluded that the effect of pyruvate to stimulate insulin release depends on its ability to increase the concentration of reduced nicotinamide nucleotides in the islet cells.
1. In isolated pancreatic islets, pyruvate causes a shift to the left of the sigmoidal curve relating the rate of insulin release to the ambient glucose concentration. The magnitude of this effect is related to the concentration of pyruvate (5-90mM) and, at a 30mM concentration, is equivalent to that evoked by 2mM-glucose. Pyruvate also enhances insulin release in the presence of fructose, leucine and 4-methyl-2-oxopentanoate. 2. In the presence of glucose (8mM), the secretory response to pyruvate is an immediate process, displaying a biphasic pattern. 3. The insulinotropic action of pyruvate coincides with an inhibition of 45Ca efflux and a stimulation of 45Ca net uptake. The relationship between 45Ca uptake and insulin release displays its usual pattern in the presence of pyruvate. 4. Exogenous pyruvate rapidly accumulates in the islets in amounts close to those derived from the metabolism of glucose. The oxidation of [2-14C] pyruvate represents 64% of the rate of [1-14C]pyruvate decarboxylation and, at a 30mM concentration, is comparable with that of 8mM-[U-14C]glucose. 5. When corrected for the conversion of pyruvate into lactate, the oxidation of 30mM-pyruvate corresponds to a net generation of about 314pmol of reducing equivalents/120min per islet. 6. Pyruvate does not affect the rate of glycolysis, but inhibits the oxidation of glucose. Glucose does not affect pyruvate oxidation. 7. Pyruvate (30mM) does not affect the concentration of ATP, ADP and AMP in the islet cells. 8. Pyruvate (30mM) increases theconcentration ofreduced nicotinamide nucleotides in the presence but not in the absence of glucose. A close correlation is seen between the concentration of reduced nicotinamide nucleotides and the net uptake of 45Ca. Menadione inhibits the effect of pyruvate on insulin release, without altering its rate of oxidation. 9. Pyruvate, like glucose, modestly stimulates lipogenesis. 10. Pyruvate, in contrast with glucose, markedly inhibits the oxidation of endogenous nutrients. The latter effect accounts for the apparent discrepancy between the rate of pyruvate oxidation and the magnitude of its insulinotropic action. 11. Dichloroacetate fails to affect glucose oxidation and glucose-stimulated insulin release. 12. It is concluded that the effect of pyruvate to stimulate insulin release depends on its ability to increase the concentration of reduced nicotinamide nucleotides in the islet cells.
In the preceding papers in this series (Malaisse et al., 1978b,c) , we have proposed that the generation ofreduced nicotinamide nucleotides plays an essential role in the process of glucose-induced insulin release, by coupling metabolic to subsequent cationic events in the secretory sequence. We have also postulated that any nutrient that is able, as a result of its metabolism, to increase the concentration of NAD(P)H in islet cells should be able to mimic the effect of glucose on insulin release. The present investigation, parts of which have been already reported in abstract form (Kawazu etal., 1977; Sener etal., 1978) , was primarily undertaken to verify the validity of the latter postulate for exogenous pyruvate. By analogy, our results also suggest a possible role for the mitochondrial oxidation Vol. 176 of endogenous pyruvate in the process of glucoseinduced insulin release.
Experimental Insulin release by isolated islets
Groups of eight islets each, removed from female albino rats, were incubated for 90min in 1.0ml of a bicarbonate-buffered medium containing albumin (5mg/ml), the release of insulin being measured as described elsewhere . Whenever sodium pyruvate (Sigma Chemical Co., St. Louis, MO, U.S.A.) was added to the incubation medium, the NaCl concentration was decreased accordingly to maintain a normal Na+ concentration (139mM).
Other agents added to the medium included menadione (Sigma) and cytochalasin B (Aldrich Chemical Co., Milwaukee, WI, U.S.A.).
Insulin release by the isolated perfusedpancreas
The method used for the measurement of insulin release by the isolated perfused pancreas was previously described (Van Obberghen et al., 1973) . The perfusate contained albumin (5mg/ml) and dextran (40mg/ml), as outlined elsewhere (Leclercq-Meyer et al., 1976) . Its calcium concentration was 2.0mM.
45Ca handling by the islets
For the measurement of 45Ca efflux, groups of 100 islets each were prelabelled with 45Ca and placed in a perifusion chamber, as described in detail elsewhere . In one series of experiments, verapamil (Knoll A. G., Ludwigshafen, Germany) was used to inhibit Ca entry into islet cells . For the measurement of net uptake of 45Ca, the same technique was used as that proposed for the net uptake of 42K (Boschero et al., 1977) . In that method, the islets are rapidly separated from the radioactive incubation medium by passing the latter through a layer of di-n-butyl phthalate. The net uptake of 45Ca is corrected for extracellular contamination, with [3H]sucrose as an extracellular marker.
Uptake of [14C]pyruvate by the islets
Groups of ten islets each were placed in polythene microcentrifuge tubes, preincubated for 30min in the absence of exogenous nutrients, and eventually incubated for various times in 0.05ml of a medium containing [1-14C]-or [U-14C]-pyruvate (10-25puCi/ ml) and [6,6'(n) -3H]sucrose (1.0mM; 20-25pCi/ml).
At the end of the incubation period, the islets were deposited in the bottom of the tube during a first centrifugation (5s; Beckman Microfuge, model 152). Di-n-butyl phthalate (0.1 ml; BDH Chemicals, Poole, Dorset, U.K.) was then layered on the top of the incubation medium, and a second centrifugation (10s) performed to separate the islets pellet from the medium. The lowest 2mm of the tube was removed with a scalpel, transferred to a scintillation vial containing a solution of EGTA (l.Oml, 2.0mM, pH7.0), mixed with 10ml of scintillation fluid (Insta-Gel; Packard, Downers Grove, IL, U.S.A.), and examined for 14C and 3H content. The net uptake of ['4C]pyruvate was corrected for extracellular contamination.
Endogenous pyruvate concentration in the islets
Groups of ten islets each were placed in polythene microcentrifuge tubes and incubated for 30min in media (0.1 ml) containing various concentrations of glucose. The islets were separated from the medium, as described above, except that silicone oil (0.2ml; Versilube F50, General Electric, Bergen-Op-Zoom, The Netherlands) was used instead of di-n-butyl phthalate. A solution (5,ul) of NaOH (0.02M) and sucrose (20 %, w/v) was immediately injected with aid of a microsyringe in the bottoms of the tubes, which were then placed for 10min in a water bath maintained at 80°C. Samples (4p1) either removed from the tube or taken from pyruvate standard solutions were then mixed with 10,u1 of an imidazole buffer (50mM, pH7.4) containing bovine albumin (0.3mg/ ml), ascorbate (3mM), NADH (1O0lM) and lactate dehydrogenase (0.2,ug/ml; EC 1.1.1.27), and incubated for 20min at room temperature. The remaining NADH was destroyed during a 30min incubation at room temperature, after addition of 10,ul of HCI (0.5M). The media were neutralized by addition of 5,ul of NaOH (1.0M). An enzymic cycling reagent (0.1 ml) consisting of a Tris buffer (100mM; pH8.4) containing lactate (100mM), ADP (0.3 mM), 2-oxoglutarate (5mM) and both lactate dehydrogenase (50,ug/ml) and glutamate dehydrogenase (400#g/ml; EC 1.4.1.3) was then added to the tubes, which were incubated for 60min at 37°C. The reaction was stopped by placing the tubes for 5 min in a water bath maintained at 95°C. After addition of 1.0ml of a Tris buffer (50mm, pH 8.5) containing bovine albumin (0.1 mg/mI), NAD+ (1.0mM), ADP (0.1 mM) and H202 (9.0mM) and incubation for 20min at room temperature to destroy the remaining 2-oxoglutarate, a first measurement by microfluorimetry was performed. Glutamate dehydrogenase (5,ul; 10mg/ml) was then added to the tube and a second measurement of NADH fluorescence performed after a last 30min incubation at room temperature.
No detectable loss of pyruvate occurred during 10-min incubation at 80°C in the presence of NaOH (0.02-0.04M). In calculating the concentration of pyruvate in the islets, correction was made for the blank values found with incubation media containing no islets. In arbitrary units such a blank averaged 135.0 ± 5.7 (n = 4) as distinct from experimental values ranging between 156.4 ± 7.7 (n = 11) and 219.1 ± 7.4 (n = 11). By using the same mode of expression and by combining the S.E.M. on both the blank of the standard curve (117.0+5.6; n = 4) and the lowest standard amount (3.13pmol/4p1) of pyruvate (136.0 ±4.4; n = 4), the limit of sensitivity of the assay was found to amount to 1.17pmol/4u1 (corresponding to 0.15 pmol/islet). Conversion ofpyruvate into lactate in the islets Groups of 50 islets each were incubated for 120 min at 37°C in 0.1 ml of the usual medium. The lactate present in the islets and incubation medium was assayed by an enzymic procedure described in detail elsewhere (Sener & Malaisse, 1976) .
Concentration ofadenine nucleotides in the islets
Groups of eight islets each were incubated for 30min in 0.06ml of medium. The determination of ATP, ADP and AMP was carried out as described elsewhere (Malaisse et al., 1978b) .
Concentration of reduced nicotinamide nucleotides in the islets
Groups of ten islets each were incubated for 30min in 0.06ml of medium. The total concentration of reduced nicotinamide nucleotides (NADH + NADPH) was assayed by the luciferase technique, as previously reported (Malaisse et al., 1978b) .
Incorporation of IH20 into islet lipids
Groups of 20 islets each were incubated for 120min
in 0.05 ml of medium containing 3H2O (250mCiIml).
At the end of the incubation and after removal of most of the incubation medium, the residual radioactive medium was diluted by addition of 0.2ml of Vol. 176 ice-cold medium, and the islets were separated from this medium by the oil-centrifugation technique previously described. (Jungas, 1968; Brunengraber, 1976) .
Oxidation of endogenous nutrients For measuring the oxidation of endogenous nutrients, the islets were prelabelled with [U-14C]palmitate (Berne, 1975 Various substrates and drugs were tested for their ability to replace glucose as an apparent permissive factor for the insulinotropic action of 30mM-pyruvate (Table 2) . In this respect, 2-deoxyglucose, 3-0-methylglucose, xylitol and malate were unable to replace glucose. Theophylline, cytochalasin B and ouabain also failed to enhance significantly the closeto-basal rate of insulin release found in the presence of 30mM-pyruvate. However, in the presence of fructose, glyceraldehyde, leucine or 4-methyl-2-oxopentanoate, pyruvate significantly enhanced insulin output. The results obtained with fructose are especially striking in that the hexose itself failed to stimulate insulin release.
Dynamics of pyruvate-induced insulin release in the isolatedperfusedpancreas
In the isolated perfused pancreas, the administration of glucose (8.3mM) after 25min of perfusion evoked a typical secretory response, an early peak being followed by a slow and progressive build-up in insulin output (Fig. 3 ). When pyruvate (30.0mM) was administered during exposure of the pancreas to glucose (8.3mM), a biphasic secretory response was again observed that was superimposed on the release pattern seen in the sole presence of glucose (Fig. 3) . Over the 20min of exposure to pyruvate (41-60min of perfusion), the integrated output of insulin averaged 4.34±0.49m-i.u./pancreas, as distinct from a control value (glucose alone) of 2.48±0.42m-i.u./ pancreas (P<0.02; n = 6 in each case). In the absence of glucose, pyruvate failed to stimulate insulin release (Fig. 3 ). When the pancreas was first exposed to pyruvate (30.0mm), which was delivered throughout the experimental procedure, the administration of glucose (at 25 min) evoked a more rapid release of insulin than that normally seen in response to the sugar (i.e. in the absence of pyruvate). Thus in the presence of pyruvate, the values for insulin output at 26min averaged 92 ± 28p-i.u./min per pancreas (n = 7), as distinct from only 12 ± 4,p-i.u./min per pancreas (n = 12) in the control experiments (P<0.005). The integrated output of insulin provoked by glucose (8.3mM) between 25 and 39min was also significantly higher (P<0.05) in the presence (1.97±0.32m-i.u./ pancreas; n = 7) than in the absence (1.26 ± 0.11 mi.u./pancreas; n = 12) of pyruvate (results not shown).
Alteration ofpyruvate-induced insulin release
In the presence of menadione (0.01 mM), the secretory response to 11.1 mM-glucose is severely decreased, but not abolished (Malaisse et al., 1978c) , so that the actual rate of insulin release is comparable with that normally seen at 8.3 mm-glucose in the absence of menadione (Table 2 , lines 2 and 3). Despite such a similarity in secretory rate, the increment in insulin output attributable to pyruvate (30mM) was about half as much (P<0.05) in the presence of 11.1 mM-glucose and 0.01 mM-menadione (pyruvate-induced increment in insulin output +34.2±11.6,u-i.u./90min per islet) as that seen in the sole presence of 8.3 mM-glucose (pyruvateinduced increment + 67.9 ± 5.7u-i.u./90min per islet). The latter observation suggests that menadione also impairs the proper insulinotropic action of pyruvate. And indeed, comparison with previously reported data (see Fig. 2 in Malaisse et al., 1978c) indicates that the fractional decrease in insulin output attributable to 0.01 mi-menadione was the same whether glucose alone or a combination of glucose and pyruvate was used to stimulate insulin release at a given secretory rate.
When the islets are preincubated for 90min in the absence of glucose, the capacity of the sugar to stimulate insulin release is apparently somewhat impaired (Matschinsky et al., 1972 (Fig. 4) pyruvate concentrations of 1.0, 5.0 and 30.0mM respectively. For the purpose of comparison, we measured the concentration of endogenous pyruvate found in islets exposed to glucose. After 30min incubation, the concentration of endogenous pyruvate (pmol/islet) increased from a basal value of 0.54± 0.08 (n = 28) to 0.95±0.08 (n = 22) and 1.37+ 0.10 (n = 28) as the glucose concentrations were raised to 8.3 and 16.7 mm respectively.
The oxidation of pyruvate progressively increased as its concentration was raised from 1.0 to 30.Omm (Fig. 7) . As is the case for the effect of pyruvate on insulin release (see Fig. 1 (Fig. 8) . In terms of 14C02 output, the rate of oxidation of 30mM-[U-_4C]pyruvate was higher than that of 8.3 mM-[U-_4C]glucose (Fig. 8) .
The oxidation of pyruvate was inhibited by anoxia, antimycin A, KCN and iodoacetate, but unaffected by menadione (Table 4) (Table 5) , even at a very high concentration of the sugar (27.8mM). However, both leucine (20mM) and 4-methyl-1-oxopentanoate (10mM) were able to decrease [2-14C]pyruvate oxidation.
As little as 5 mM-pyruvate was sufficient to cause a significant decrease in the output of 14CO2 from [U-'4C]glucose (Table 5) (Table 6 ). As expected from previous investigations (Ashcroft et al., 1973; Malaisse et al., 1978b) , glucose itself significantly increased the concentration of ATP, the ATP/ADP ratio and the adenylate charge (P<0.01 or less) in the islet cells.
Effect of pyruvate on the concentration of reduced nicotinamide nucleotides
The total concentration of reduced nicotinamide nucleotides (NADH+NADPH) was measured at 30min of incubation in islets exposed to glucose and/ or pyruvate (Table 7) . Pyruvate (30.0mM) failed to increase significantly the concentration of reduced nicotinamide nucleotides above the basal value. As expected from previous observations (Malaisse et al., 1978b) , glucose (8.3mM) significantly increased (P<0.005) the concentration of NADH+NADPH. Pyruvate, in the presence of glucose, further enhanced (P <0.05) the concentration of reduced nicotinamide nucleotides.
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There was a highly significant correlation (r = 0.981; n = 5; P <0.005) between the total concentration of reduced nicotinamide nucleotides and the mean corresponding values for the net uptake of 45Ca (Fig. 5a ).
Effect ofpyruvate on lipogenesis
As judged from the incorporation of 3H20 in islet lipids, the synthesis of lipids found in the absence of exogenous substrate averaged 8.91 ± 1.58 pmol of acetyl-CoA residues/120min per islet (Table 8) . About 80% of the newly synthesized lipids corresponded to phospholipids and mono-or tri-acylglycerols. Antimycin A suppressed basal lipogenesis.
Glucose (16.7 mM) significantly (P < 0.005) augmented lipogenesis, above basal value. Pyruvate (30.0mM) mimicked, to a limited extent, the effect of glucose. By comparison with the basal data, the lipids synthesized in response to pyruvate were recovered in both the non-esterified fatty acid and triacylglycerol fractions, whereas, in response to glucose, they represented mostly triacylglycerols.
Effect of pyruvate on the utilization of endogenous nutrients
To assess the effect of glucose and pyruvate on the oxidation of endogenous nutrients, the islets were preincubated for 120min in the presence of [U-12C]glucose (8.3 mM) and [U-14C]palmitate (0.27mM) and then washed to remove extracellular nutrients. The incorporation of radioactivity in the islets corresponded to a net uptake of 1.93 ± 0.05 pmol of palmitate/islet (n = 121). This radioactivity was distributed as outlined in Table 9 .
After washing, the islets were incubated for 120 min in the absence or presence of exogenous nutrients.
Both the output of "4CO2 and the final radioactive content of the islets were measured.
In the absence of exogenous nutrients, the output of "4CO2 averaged 4.56±0.19% (n = 31) of the final radioactive content of the islets ( 
mM).
Assuming that the present data are representative of the overall decrease in the utilization of endogenous nutrients and by using the basal rate of 02 consumption in the present system as a reference value, we estimated to what extent the glucose-and pyruvateinduced fall in "4CO2 output, as documented in Table 10 , may affect the net generation rate of reducing equivalents relative to the basal value found in the absence of exogenous nutrients. As illustrated in Table 11 , when corrected in such a way, the net gain in reducing equivalents above basal value was much lower in the presence of pyruvate than glucose. As a matter of fact, the mean value found with 30mM-pyruvate represented 23.0% of that found Figs. 1 and 3 ). The effect of pyruvate is modest relative to that of glucose (Fig. 2) . In most previous studies with pancreatic tissue from fed adult animals, pyruvate (5-20mM) was reported not to stimulate insulin secretion (Coore & Randle, 1964; Montague & Taylor, 1969; Matschinsky & Ellerman, 1973; Lenzen et al., 1976) . It should be noted, however, that such studies were invariably carried out at either low (2.0-3.3 mM) or high (16.7-27.8 mM) glucose concentrations, namely under conditions that are not optimal for characterizing the insulinotropic action of pyruvate (Fig. 2) . A dose-related Table 11 . Tentative and partial balance sheet for the generation and utilization of reducing equivalents in islets exposed to pyruvate (30mM) or glucose (8.3 mM) The absolute value for the utilization of endogenous nutrients was derived from the basalOI uptake, which, in the present system, averages 176.1 ± 19.7 pmol of 02/60min per islet (n = 23; J. C. Hutton &W. J. Malaisse, unpublished work).
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(pmol/120min per islet) effect of pyruvate on insulin release, comparable with that illustrated in Fig. 1 , was already observed in cultured explants of foetal rat pancreas incubated in the presence of 10mM-caffeine (Lambert, 1970) . The present study is aimed at re-evaluating the effect of pyruvate on islet function within the framework of recent investigations that suggest that the insulinotropic action of different nutrients is related to their readiness to be metabolized and to increase the concentration of reduced nicotinamide nucleotides in islet cells (Malaisse et al., 1978b,c) .
Insulinotropic action ofpyruvate
At first glance the present data seemed incompatible with the above-mentioned hypothesis. Indeed, up to 30.0 mM, pyruvate, although being readily oxidized by the islets (Figs. 7 and 8 ), failed to stimulate insulin release in the absence of glucose (Table 1, Fig. 3 ). The failure of 30mM-pyruvate to provoke insulin release in the absence of glucose was confirmed by the fact that, even in the presence of theophylline and cytochalasin B, compounds that invariably augment stimulated insulin output, the rate of secretion remained close to its basal value (Table 2 ). In the absence of glucose, pyruvate also fails to stimulate proinsulin biosynthesis (Lin & Haist, 1969) .
Whereas glucose slightly decreases the steady-state values for net uptake of 22Nat by the islets , pyruvate tends to exert an opposite effect. Thus after 90min incubation in the presence of pyruvate (30.0mM), the net uptake of Na+ averaged 171.6± 17.0pmol/islet (n = 17) as distinct from a basal value of 143.0±1.6pinol/islet (n = 14). We considered, therefore, that the transport of pyruvate in islet cells might somehow be associated with an increased inflow of Na+ and hence with a higher activity of the membrane-associated (Na+ + K+)-activated adenosine triphosphatase. However, even in the presence of ouabain, pyruvate failed to stimulate insulin release (Table 2) .
A significant effect of pyruvate (30.0 mM or less) on insulin secretion was only detected in the presence of Vol. 176 glucose or other insulinotropic nutrients, such as fructose, glyceraldehyde, leucine and 4-methyl-2-oxopentanoate (Table 2 , Fig. 1) . The relationship between the glucose concentration of the incubation medium and the magnitude of the proper insulinotropic action of pyruvate clearly indicates that pyruvate should be considered as a glucose-simulating agent, as defined elsewhere (Malaisse, 1973) . Thus pyruvate shifts to the left the sigmoidal curve relating insulin output to the ambient glucose concentration (Fig. 2) . The magnitude of such a shift is related to the concentration of pyruvate (Fig. 1) . When the latter concentration is sufficiently high, a significant but modest increase in insulin output is evoked by pyruvate in the absence of glucose (Table 1) . Incidentally, the view that pyruvate mimics the effect of glucose does not imply that the modality by which pyruvate and glucose respectively stimulate insulin release cannot be distinguished from one another. And indeed, the data collected after a preincubation of 90 min in the absence of glucose suggest that such a prior nutritional manipulation decreases more markedly the insulinotropic capacity of glucose than that of pyruvate. Likewise, when the pancreas is removed from starved or hyperthyroidic rats, the secretory response to glucose (16.7mM) is impaired, so that the enhancing action of exogenous pyruvate can now be documented at this high glucose concentration (Lenzen et al., 1975) .
The pyruvate-induced shift to the left of the sigmoidal curve relating insulin output to glucose concentration indicates that the effect of 30.OmMpyruvate is comparable with that of 2.0mM-glucose. The major aim of the present study was to discover whether such a difference could be explained by the different metabolic situations found in the islets exposed to glucose and pyruvate. The experimental findings are compatible with the view that pyruvate, like glucose (Malaisse et al., 1978b,c) , stimulates insulin release through a sequence of events involving (i) the metabolism of the nutrient, (ii) a resulting increase in the concentration of reduced nicotinamide nucleotides, (iii) a subsequent remodelling of calcium fluxes in the islet cells, and (iv) the eventual activation by intracellular calcium of the insulin-releasing effector system.
Metabolism ofpyruvate in the islets
In considering the metabolism of pyruvate in the islets, it should be first remembered that the islets represent a heterogeneous cell population including not only insulin-producing cells.
Exogenous pyruvate rapidly accumulated in the islet cells (Fig. 6 ). An ionophoretic rather than diffusional process probably mediates the entry of pyruvate in islet cells, as in other tissues (Spencer & Lehninger, 1976; Halestrap, 1976) . Taking into account the intracellular water space of the islets (2-3nl/islets; see Malaisse et al., 1976) (Fig. 7) . The oxidation of pyruvate was decreased in the presence of either leucine or 4-methyl-2-oxopentanoate (Table 5 (Gunnarsson & Hellerstrom, 1973) .
A fraction of the exogenous pyruvate taken up by the islets was converted into lactate. The latter phenomenon was taken into account when calculating the rate of generation of reducing equivalents in the islets exposed to pyruvate (Table 11) (Table 7) . Secondly, and as already observed under other experimental conditions (Malaisse et al., 1978b) , there was a tight proportionality (Fig. Sa) between the steady-state concentration of NADH+NADPH and the size of the exchangeable pool(s) of calcium, as judged from the net uptake of 45Ca. And thirdly, menadione inhibited the effect of pyruvate on insulin release (Table 2) . We have previously indicated that the inhibitory effect of 0.01 mM-menadione on glucose-induced insulin release is indeed attributable to a fall in the concentration of reduced nicotinamide nucleotides rather than to any abnormality in glucose metabolism (Malaisse et al., 1978b) . Likewise, at the-same concentration (0.01 mM), menadione impaired the insulinotropic action of pyruvate, but failed to affect its rate of oxidation (Table 4) . The modality by which reducing equivalents may affect cation transport by native ionophoretic systems in the islet cells was previously considered (Malaisse et al., 1978a) .
Participation of calcium in pyruvate-induced insulin release
The involvement of calcium in the insulinotropic action of pyruvate is supported by the finding that the usual relationship between the net uptake of 45Ca and the rate of insulin release, as previously documented under a variety of experimental conditions (MalaisseLagae & Malaisse, 1971) , was also applicable to the process of pyruvate-induced insulin release (Fig. 5b) . Moreover, pyruvate mimicked the ability of glucose to lower the efflux of 45Ca from islets exposed to a Ca2+-free medium (Fig. 4) Fig. 5b ). In this respect, the effect of pyruvate (30.0mM) in the absence of glucose resembles that of low glucose concentrations (up to 4.5 mm), which also affect calcium handling without causing insulin release (Herchuelz & Mahy, 1974) .
Interference ofpyruvate with the utilization of endogenous nutrients It remained to be understood why pyruvate (30.0mM), although oxidized at a higher rate (Fig. 8) than glucose (8.3 mM), was much less efficient than the sugar in raising the concentration of reduced nicotinamide nucleotides, as already observed by Panten et al. (1973) . The rate of pyruvate conversion into lactate was not sufficiently high to account fully for this discrepancy (Table 11 ). The effect of pyruvate and glucose on the rate of lipogenesis (Table 8 ) also failed to account for the discrepancy. The latter was apparently attributable to the fact that pyruvate exerts a more pronounced inhibitory effect than does glucose on the utilization of endogenous nutrients (Table 10) . Indeed, when corrected for such a phenomenon, the net generation of reducing equivalents in the presence of glucose and pyruvate became strictly proportional to their insulinotropic capacity (Table 1 1 ).
The findings illustrated in Table 11 are in good agreement with previous reports indicating that the rate of 02 consumption by isolated islets is increased much more (above its basal value) by glucose than by pyruvate (Hedeskov et al., 1972; . For glucose, it was already underlined that the sugar-induced increase in 02 consumption coincides with the amount of 02 required for the oxidation of exogenous glucose (Hellerstrom & Gunnarsson, 1970) . Our data support this observation, since they suggest that glucose only exerts a marginal effect on the utilization of endogenous nutrients.
The calculations outlined in Table 11 , which suggest that the overall gain in reducing equivalents is relatively modest in the presence of exogenous pyruvate, could also explain why pyruvate, in contrast with glucose, fails to prevent the fall in ATP concentration and adenylate charge (Table 6 ) normally seen when islets are incubated in the absence of exogenous nutrients (Ashcroft et al., 1973; Malaisse et al., 1976) . Vol. 176 At this point it should be mentioned that the metabolic situation found in the concomitant presence of glucose and pyruvate may not strictly coincide with that expected from the summation of the individual effects of each nutrient. First, and as already discussed, allowance should be made for the reciprocal influence of glucose and pyruvate on their respective oxidation rates (Table 5) . Secondly, the data outlined in Table 10 (Randle, 1976) . However, dichloroacetate failed to affect both glucose oxidation and glucose-stimulated insulin release (Table 12 ). These negative data obviously do not rule out a possible role for the oxidation of endogenous pyruvate in the normal secretory response evoked by glucose in the islets.
Taken as a whole, the findings outlined in the present paper could even raise the question as to whether, in the stimulus-secretion coupling of glucose-induced insulin release, glycolysis plays any role other than being the major pathway for the conversion of glucose into endogenous pyruvate and contributing modestly to the overall generation rate of reduced nicotinamide nucleotides, which would be mostly derived from the mitochondrial oxidation of pyruvate.
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